Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Cumberland MJ, Euchner J, Azad AJ, Vo NTN, Kirchhof P, Holmes AP, Denning C, Gehmlich K. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model. F1000Res. 2023;12:1224.

Gagne AL, Maguire JAnn, Gandre-Babbe S, Chou ST, Tasian SK, Loh ML, Weiss MJ, Gadue P, French DL. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.

Fatima A, Schuster J, Akram T, Sobol M, Hoeber J, Dahl N. Generation of a human Neurochondrin deficient iPSC line KICRi002-A-3 using CRISPR/Cas9. Stem Cell Res. 2020;44:101758.

Baulier E, Diaz AGarcia, Corneo B, Farber DB. Generation of a human Ocular Albinism type 1 iPSC line, SEIi001-A, with a mutation in GPR143. Stem Cell Res. 2018;33:274-277.

Yamashita T, Kamiya D, Kawaraichi N, Toyokawa H, Akaboshi T, Ikeya M, Toyooka Y. Generation of a human SOX10 knock-in reporter iPSC line for visualization of neural crest cell differentiation. Stem Cell Res. 2022;60:102696.

Perik M, Verstraeten A, Nijak-Paeske A, Rabaut L, Van Laer L, Loeys B. Generation of a human TGFB3-hIPSC line, BBANTWi010-A, from a Loeys-Dietz syndrome type V patient. Stem Cell Res. 2022;65:102956.

Wilken MB, Maguire JAnn, Dungan LV, Gagne A, Osorio-Quintero C, Waxman EA, Chou ST, Gadue P, French DL, Thom CS. Generation of a human Tropomyosin 1 knockout iPSC line. Stem Cell Res. 2023;71:103161.

Guo J, Fang F, Dai Q, Zhang W, Di W, Hu J, Zhao J, Cao J, Wang Y. Generation of a human-derived induced pluripotent stem cell line (SIAISi012-A) from an 82-year-old healthy Chinese Han male. Stem Cell Res. 2021;52:102186.

Hou X, Fan W, Zeng J, Gao Z, Wan J, Liao B. Generation of a ISL1 homozygous knockout stem cell line (WAe009-A-1G) by episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2024;76:103376.

Wu F, Li X, Bai R, Li Y'nan, Gao J, Lan F. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2020;48:101930.

Ordoño J, Pérez-Amodio S, Ball K, Aguirre A, Engel E. The generation of a lactate-rich environment stimulates cell cycle progression and modulates gene expression on neonatal and hiPSC-derived cardiomyocytes. Biomater Adv. 2022:213035.

Lu J-Z, Bin Qiao Z-, Zhang L, Cao H-X, Bai Z-H, Qi Y-Y, Zhu H-Y, Chen Y-Q, Zhang S-M, Yan X-H, et al. Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the LMNA gene by CRISPR/Cas9 technology. Stem Cell Res. 2021;56:102530.

Kung LHW, Sampurno L, Little CB, Lamandé SR, Bateman JF. Generation of a miR-26b stem-loop knockout human iPSC line, MCRIi019-A-1, using CRISPR/Cas9 editing. Stem Cell Res. 2020;50:102118.

Gulimiheranmu M, Li S, Zhou J. Generation of a MIR5004 knockout cell line from human induced pluripotent stem cells by CRISPR/Cas9 gene editing. Stem Cell Res. 2022;62:102805.

Chiu W, Li A, Wang T, Li W, Zhang X. Generation of a MSX1 knockout human embryonic stem cell line using CRISPR/Cas9 technology. Stem Cell Res. 2022;60:102729.

Lee Y, Choi HYoung, Kwon A, Park H, Park M, Kim Y-O, Kwak S, Koo SKyung. Generation of a NESTIN-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-1, using CRISPR/Cas9 nuclease. Stem Cell Res. 2019;40:101554.

Olmer R, Dahlmann J, Merkert S, Baus S, Göhring G, Martin U. Generation of a NKX2.1 knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-2). Stem Cell Res. 2019;39:101492.

Yi T, Bai R, Sun H, Lan F, Zhang H, He Y. Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing. Stem Cell Res. 2020;47:101893.

Omori S, Wang T-W, Johmura Y, Kanai T, Nakano Y, Kido T, Susaki EA, Nakajima T, Shichino S, Ueha S, et al. Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16 Cells In Vivo. Cell Metab. 2020.

Zhang M, Ibañez DP, Fan W, Liu H, Zhong X, Wang X, Li Y, Abdul MMd, Li W, Li Y, et al. Generation of a PARK2 homozygous knockout induced pluripotent stem cell line (GIBHi002-A-1) with two common isoforms abolished. Stem Cell Res. 2019;41:101602.

Kim B-Y, Ko JMin, Park M-H, Koo SKyung. Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation. Stem Cell Res. 2019;41:101622.

Geryk M, Canac R, Forest V, Lindenbaum P, Girardeau A, Baudic M, Baron E, Bibonne A, Chariau C, Kyndt F, et al. Generation of a patient-specific induced pluripotent stem cell line carrying the DES p.R406W mutation, an isogenic control and a DES p.R406W knock-in line. Stem Cell Res. 2024;77:103396.

Djemai M, Jauvin D, Poulin H, Chapotte-Baldacci C-A, Chahine M. Generation of a patient-specific iPSC cell line with cardiac arrhythmias and dilated cardiomyopathy (CBRCULi016-A), an isogenic control (CBRCULi016-A-1), and a paternal control (CBRCULi017-A). Stem Cell Res. 2024;75:103308.

Jo S, Kim J-W, Noh H, Kim H, Kim J-H, Park H-J. Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease. Stem Cell Res. 2023;69:103081.

Lee Y, Choi HYoung, Kwon A, Park H, Park M-H, Kim J-W, Kim MJung, Kim Y-O, Kwak S, Koo SKyung. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system. Stem Cell Res. 2019;41:101632.

Pages